Inhibition of cysteine protease disturbs the topological relationship between bone resorption and formation in vitro
Authors:
Open Access
- 20 February 2024
- journal article
- research article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 42 (2) , 166-184
Abstract
Introduction: Osteoporosis is a global health issue. Bisphosphonates that are commonly used to treat osteoporosis suppress both bone resorption and subsequent bone formation. Inhibition of cathepsin K, a cysteine proteinase secreted by osteoclasts, was reported to suppress bone resorption while preserving or increasing bone formation. Analyses of the different effects of antiresorptive reagents such as bisphosphonates and cysteine proteinase inhibitors will contribute to the understanding of the mechanisms underlying bone remodeling. Materials and Methods: Our team has developed an in vitro system in which bone remodeling can be temporally observed at the cellular level by 2-photon microscopy. We used this system in the present study to examine the effects of the cysteine proteinase inhibitor E-64 and those of zoledronic acid on bone remodeling. Results: In the control group, the amount of the reduction and the increase in the matrix were correlated in each region of interest, indicating the topological and quantitative coordination of bone resorption and formation. Parameters for osteoblasts, osteoclasts, and matrix resorption/formation were also correlated. E-64 disrupted the correlation between resorption and formation by potentially inhibiting the emergence of spherical osteoblasts, which are speculated to be reversal cells in the resorption sites. Conclusion: These new findings help clarify coupling mechanisms and will contribute to the development of new drugs for osteoporosis.Keywords
Funding Information
- The Japan Society for the Promotion of Science (JSPS) KAKENH (#18K09718, #21K10085, #22K10260)
- Naito Foundation
- The University of Tokyo
This publication has 50 references indexed in Scilit:
- Spatiotemporal Analysis of Osteoblast Morphology and Wnt Signal‐Induced Osteoblast Reactivation during Bone Modeling in VitroJBMR Plus, 2022
- Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its ExtensionJournal of Bone and Mineral Research, 2020
- Osteoclast-Derived Complement Component 3a Stimulates Osteoblast DifferentiationJournal of Bone and Mineral Research, 2014
- Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkeyJournal of Bone and Mineral Research, 2011
- Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeysJournal of Bone and Mineral Research, 2011
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001
- Matrix Metalloproteinases and Lysosomal Cysteine Proteases in Osteoclasts Contribute to Bone Resorption through Distinct Modes of ActionBiochemical and Biophysical Research Communications, 1999
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Inhibition of bone resrption by selctive inactivators of cysteine proteinasesJournal of Cellular Biochemistry, 1994
- The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitroBrain Structure and Function, 1992